Anatumomab mafenatox

DB33662ExperimentalProtein Based Therapies

Anatumomab mafenatox: Overview.

Code names
ABR-214936 ยท PNU-214936

Resolves to

Compound
UNII7E628D4GSQChEMBLCHEMBL2108248

Which companies are running trials of Anatumomab mafenatox, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In